Microbot Medical Inc [NASDAQ: MBOT] closed the trading session at $3.31 on 2025-08-20. The day’s price range saw the stock hit a low of $3.08, while the highest price level was $3.33.
The stocks have a year to date performance of 224.51 percent and weekly performance of 8.88 percent. The stock has been moved at 90.23 percent over the last six months. The stock has performed 30.83 percent around the most recent 30 days and changed 26.34 percent over the most recent 3-months.
If compared to the average trading volume of 1.76M shares, MBOT reached to a volume of 4107203 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Microbot Medical Inc [MBOT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MBOT shares is $9.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MBOT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Microbot Medical Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 13, 2020. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price from $10 to $12. The new note on the price target was released on December 24, 2019, representing the official price target for Microbot Medical Inc stock. Previously, the target price had yet another raise to $1.75, while Ladenburg Thalmann analysts kept a Buy rating on MBOT stock.
The Price to Book ratio for the last quarter was 4.14, with the Price to Cash per share for the same quarter was set at 0.72.
MBOT stock trade performance evaluation
Microbot Medical Inc [MBOT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 8.88. With this latest performance, MBOT shares gained by 30.83% in over the last four-week period, additionally plugging by 90.23% over the last 6 months – not to mention a rise of 195.54% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MBOT stock in for the last two-week period is set at 66.58, with the RSI for the last a single of trading hit 0.21, and the three-weeks RSI is set at 0.20 for Microbot Medical Inc [MBOT]. The present Moving Average for the last 50 days of trading for this stock 2.67, while it was recorded at 3.14 for the last single week of trading, and 1.97 for the last 200 days.
Microbot Medical Inc (MBOT) Capital Structure & Debt Analysis
According to recent financial data for Microbot Medical Inc. ( MBOT), the Return on Equity (ROE) stands at -69.80%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -62.65%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Microbot Medical Inc’s Return on Invested Capital (ROIC) is -41.80%, showcasing its effectiveness in deploying capital for earnings.
Microbot Medical Inc (MBOT) Efficiency & Liquidity Metrics
Based on Microbot Medical Inc’s (MBOT) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Microbot Medical Inc (MBOT) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Microbot Medical Inc. (MBOT) effectively leverages its workforce, generating an average of -$605238.1 per employee. The company’s liquidity position is robust, with a Current Ratio of 12.06% and a Quick Ratio of 12.06%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for Microbot Medical Inc [MBOT] stock
With the latest financial reports released by the company, Microbot Medical Inc posted -0.2/share EPS, while the average EPS was predicted by analysts to be reported at -0.17/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.03. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MBOT.
Microbot Medical Inc [MBOT]: Institutional Ownership
There are presently around $10.01%, or 10.02%% of MBOT stock, in the hands of institutional investors. The top three institutional holders of MBOT stocks are: VANGUARD GROUP INC with ownership of 0.46 million shares, which is approximately 3.0953%. BLACKROCK INC., holding 0.14 million shares of the stock with an approximate value of $$0.14 million in MBOT stocks shares; and BLACKROCK INC., currently with $$0.12 million in MBOT stock with ownership which is approximately 0.8078%.
